Serina Therapeutics (SER) Stock Price, Quote, News & History | Benzinga

Serina Therapeutics Inc (SER) Stock Price, Quote, News & History

SERAMEX

Trade with Public

Trade with Public

$2.46

-0.06-2.38%

At close: Aug 28, 5:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$2.52

Close

$2.46

Volume / Avg.

33.96K / 78.17K

Day Range

$2.41 - $2.53

52 Wk Range

1.22 - 5.83

Market Cap

$64.01M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

48

Short Interest

0.66%

Days to Cover

2.1

Recent Serina Therapeutics, Inc. News

Stock Market Today: Futures Drop Ahead Of 'Triple Witching' Session As Iran Threatens 'Zero Restraint'— FedEx, Super Micro In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.) U.S. stock futures declined on Friday following Thursday’s declines. Futures of the major benchmark indices were lower.

Rishabh Mishra

Gold Tumbles Over 6%; Accenture Earnings Top Views

Avi Kapoor

Dow Falls Over 300 Points; US Initial Jobless Claims Fall

US stocks down, Dow falls 300+ points, S&P 500 drops 0.93%, Nasdaq falls 1.25%. Energy shares up, materials down. Initial jobless claims down 8,000.

Avi Kapoor

Why Five Below Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4 results and issuing strong FY26 EPS guidance. Other gainers include LBGJ, ASNS, SVRN, SUNE, MDAI, SER, VACH, SBDS, and VG. Losers include WNW, RVPH, RYDE, and AZI.

Avi Kapoor

Serina Therapeutics (SER) Stock Surges Over 39% After Hours— Here's Why

Serina Therapeutics Inc. surged 39.45% in after-hours trading Wednesday following a $15 million private placement announcement.

Mohd Haider

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-21.14M

Investing Cash Flow (TTM)

-66.00K

Financing Cash Flow (TTM)

38.18M

Free Cash Flow (TTM)

-21.20M

Capital Expenditure (TTM)

-66.00K

Net Change in Cash (TTM)

16.98M

Analyst Trends and Forecast

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$42.67M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.42

Earnings Yield % (TTM)

-74.21%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.74

Company Debt

Total Debt

$3.09M

LT Debt

$3.09M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$23.02M

Debt to Equity

0.17

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$2.52

Close

$2.46

Volume / Avg.

33.96K / 78.17K

Day Range

$2.41 - $2.53

52 Wk Range

1.22 - 5.83

Market Cap

$64.01M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

48

Short Interest

0.66%

Days to Cover

2.1

About

Sector

Health Care

Industry

Biotechnology

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in dru...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Serina Therapeutics (SER) stock?

A

You can purchase shares of Serina Therapeutics (AMEX:SER) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Serina Therapeutics (SER) competitors?

A

Other companies in Serina Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Serina Therapeutics (SER) stock?

A

Serina Therapeutics has a consensus price target of $11.33.

Q

What is the current price for Serina Therapeutics (SER)?

A

The stock price for Serina Therapeutics (AMEX: SER) is $ last updated .

Q

Does Serina Therapeutics (SER) pay a dividend?

A

There are no upcoming dividends for Serina Therapeutics.

Q

When is Serina Therapeutics (AMEX:SER) reporting earnings?

A

Serina Therapeutics does not have any upcoming earnings scheduled.

Q

Is Serina Therapeutics (SER) going to split?

A

There is no upcoming split for Serina Therapeutics.

Q

What sector and industry does Serina Therapeutics (SER) operate in?

A

Serina Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.